CN102166324A - Medicament for treating skin infection diseases - Google Patents
Medicament for treating skin infection diseases Download PDFInfo
- Publication number
- CN102166324A CN102166324A CN 201110086467 CN201110086467A CN102166324A CN 102166324 A CN102166324 A CN 102166324A CN 201110086467 CN201110086467 CN 201110086467 CN 201110086467 A CN201110086467 A CN 201110086467A CN 102166324 A CN102166324 A CN 102166324A
- Authority
- CN
- China
- Prior art keywords
- extract
- medicament
- skin
- skin infection
- infection diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 20
- 206010040872 skin infection Diseases 0.000 title claims abstract description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 230000000694 effects Effects 0.000 abstract description 8
- 206010017533 Fungal infection Diseases 0.000 abstract description 3
- 208000031888 Mycoses Diseases 0.000 abstract description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract description 3
- 239000003242 anti bacterial agent Substances 0.000 abstract description 3
- 229940088710 antibiotic agent Drugs 0.000 abstract description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 abstract description 2
- JBIROUFYLSSYDX-UHFFFAOYSA-M benzododecinium chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 JBIROUFYLSSYDX-UHFFFAOYSA-M 0.000 abstract description 2
- 229960002152 chlorhexidine acetate Drugs 0.000 abstract description 2
- 230000002045 lasting effect Effects 0.000 abstract description 2
- 229960003512 nicotinic acid Drugs 0.000 abstract description 2
- 235000001968 nicotinic acid Nutrition 0.000 abstract description 2
- 239000011664 nicotinic acid Substances 0.000 abstract description 2
- 230000003389 potentiating effect Effects 0.000 abstract description 2
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 abstract description 2
- 229910052957 realgar Inorganic materials 0.000 abstract description 2
- 229910021642 ultra pure water Inorganic materials 0.000 abstract description 2
- 239000012498 ultrapure water Substances 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 3
- 231100000331 toxic Toxicity 0.000 abstract 2
- 230000002588 toxic effect Effects 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000253115 Carpesium Species 0.000 abstract 1
- 241000212948 Cnidium Species 0.000 abstract 1
- 241000972672 Phellodendron Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 241001671204 Stemona Species 0.000 abstract 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 5
- YRAQEMCYCSSHJG-NSHDSACASA-N (S)-columbianetin Chemical compound C1=CC(=O)OC2=C1C=CC1=C2C[C@@H](C(C)(O)C)O1 YRAQEMCYCSSHJG-NSHDSACASA-N 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 201000004681 Psoriasis Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 2
- HPUXDMUGCAWDFW-UHFFFAOYSA-N Osthole Natural products COc1ccc2CCC(=O)Oc2c1C=CC(=O)C HPUXDMUGCAWDFW-UHFFFAOYSA-N 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 206010072170 Skin wound Diseases 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- YRAQEMCYCSSHJG-UHFFFAOYSA-N Tetrahydro-oroselol Natural products C1=CC(=O)OC2=C1C=CC1=C2CC(C(C)(O)C)O1 YRAQEMCYCSSHJG-UHFFFAOYSA-N 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000001217 buttock Anatomy 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- MBRLOUHOWLUMFF-UHFFFAOYSA-N osthole Chemical compound C1=CC(=O)OC2=C(CC=C(C)C)C(OC)=CC=C21 MBRLOUHOWLUMFF-UHFFFAOYSA-N 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- RNKZFOIQKCQOAQ-UHFFFAOYSA-N Isopimpinellin Natural products COC1CC(=O)Oc2c(OC)c3occc3cc12 RNKZFOIQKCQOAQ-UHFFFAOYSA-N 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- DQISGWRLCDLKJI-UHFFFAOYSA-N columbianetin Natural products C1=CC(=O)OC2=C(C(C(C(C)(O)C)O3)O)C3=CC=C21 DQISGWRLCDLKJI-UHFFFAOYSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- DFMAXQKDIGCMTL-UHFFFAOYSA-N isopimpinellin Chemical compound O1C(=O)C=CC2=C1C(OC)=C1OC=CC1=C2OC DFMAXQKDIGCMTL-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a medicament for treating skin infection diseases, which aims to solve the problem of toxic and side effects in the conventional medicaments. The medicament consists of the following raw materials: dodecyl dimethyl benzyl ammonium chloride, cetyl trimethyl ammonium bromide, chlorhexidine acetate, niacin, nicotinamide, common cnidium fruit extract, belvedere fruit extract, alum, sessile stemona root extract, realgar extract, phellodendron extract, lightyellow sophora root extract, honeysuckle flower extract, densefruit pittany root-bark extract, borneol, common carpesium fruit extract and ultrapure water. The medicament for treating the skin infection diseases is mainly prepared from Chinese medicinal extract, does not have antibiotics and secondary fungal infection during continuous long-term use, is balanced in medicinal properties, mild, lasting and potent, and does not have toxic or side effect.
Description
Technical field
The present invention relates to a kind of medicine that is used for the treatment of the skin infection disease.
Background technology
Skin is the good barrier of resisting bacterial infection.Though a lot of antibacterials are arranged on the normal skin, generally can not cause infection.But because skin hyperhidrosis, humidity have caused a more damp and hotter environment, for many microbial growths and breeding provide good condition, so when skin was cut or abrade, the sickness rate of skin infection was than higher.When skin infection takes place, generally be the medicine for external use of on skin, smearing antibiotics, but this medicine life-time service continuously, otherwise very easily produce the fungal infection of secondary.
Summary of the invention
For overcoming above-mentioned defective, the object of the present invention is to provide a kind of medicine of treatment skin infection disease without any side effects.
For achieving the above object, the present invention is used for the treatment of the medicine of skin infection disease, it is characterized in that, is made up of the raw material of following weight parts:
The above-mentioned medicine that is used for the treatment of the skin infection disease based on Chinese medicine extraction liquid, does not add any antibiotic, and life-time service does not have the secondary fungal infection continuously, and property of medicine balance is gentle, lasting, potent, without any side effects.
The specific embodiment
The present invention is further illustrated below in conjunction with embodiment.
The present invention is used for the treatment of the medicine of skin infection disease, it is characterized in that, is made up of the raw material of following weight parts:
Embodiment 1
Raw material by following weight parts is formed:
Embodiment 2
Raw material by following weight parts is formed:
Embodiment 3
Raw material by following weight parts is formed:
Embodiment 4
Raw material by following weight parts is formed:
Embodiment 5
Raw material by following weight parts is formed:
In the above-mentioned raw material:
Dodecyl dimethyl benzyl ammonium chloride is a kind of cationic surfactant, belongs to non-oxidizable antibacterial, has wide spectrum, sterilization algae removal ability efficiently.
Cetyl trimethyl ammonium bromide has performances such as good infiltration, softening, emulsifying, antistatic, biological degradability and sterilization.
Chlorhexidine acetate is an antibiotic antiseptic, and staphylococcus aureus, streptococcus, escherichia coli, anaerobism propionibacterium and Candida albicans are had bactericidal action.
Nicotinic acid has stronger expansion peripheral vessels effect, helps blood circulation promoting.
Nicotiamide can be repaired impaired horny layer lipid barrier, improves skin resistance.
Fructus Cnidii provides liquid: have another name called Daucus carota L., Serpentis rice, She Li, be the samphire draft.The Fructus Cnidii nature and flavor: warm in nature, acrid in the mouth, hardship, slightly poisonous.Fructus Cnidii includes chemical constituents such as pinene, isovaleric acid borneol acetate, osthole, Columbianetin (+)-Columbianetin., bergapton, osthole, isopimpinellin; Its sterilization, antiinflammatory mechanism are obviously; Fructus Cnidii provides liquid market on sale, and strong Xinghua, Deqing county worker Co., Ltd can provide.
Fructus Kochiae extracting solution has antibacterial, antibacterial action.
Alumen has antibacterial action, the external parasite killing that can also detoxify, dampness removing to stop itchin;
Radix Stemonae extracting solution has antibacterial action to staphylococcus aureus, Staphylococcus albus, beta hemolytic streptococcus, anthrax bacillus, pneumobacillus, dysentery bacterium, Bacillus proteus, bacillus pestis, escherichia coli, bacillus pyocyaneus, Bacillus typhi, Salmonella paratyphi and Bacillus tuberculosis.
The Realgar extracting solution all has in various degree inhibitory action to staphylococcus aureus, human body tubercule bacillus, Bacillus proteus, green pus coccus and various skin fungus.
The Cortex Phellodendri extracting solution has external bacteriostasis.
The Cortex Dictamni extracting solution has heat clearing and damp drying, the detoxifying and relieving itching effect
Flos Lonicerae extractive solution has heat-clearing and toxic substances removing, the good result of anti-inflammation and sterilization.
Borneolum Syntheticum has bacteriostasis is arranged
The Fructus Carpesii extracting solution has parasite killing, heat-clearing and toxic substances removing, the effect of invigorating the spleen and regulating the stomach.
Processing method:
1) uses the various raw materials of the corresponding weight of measurer weighing, and be dissolved in the ultra-pure water;
2) with ultrasound wave acoustical generator or mixing stirring paddle dissolving mixing, leave standstill the liquid that obtains and be target liq of the present invention.
3) can be according to demand with the target liq fill in quantitative metal or plastic bottle.
Using method:
The present invention can be liquid liniment, varnish or spray.Every day 1 to 3 time, evenly masking liquid is in the affected part, is advisable to moistened surface.
Therapeutic effect: according to embodiment 1,, be 93.2% to various skin infection treatment of diseases effective percentage such as psoriasis, skin pruritus, tinea capitis to 78 routine patients' uses of certain hospital, cure rate 81%.
The typical case falls ill:
(1) model case (psoriasis): Korea Spro, man, 52 years old, the boss of individual enterprise.
Diagnostic Time: on April 26th, 2009
According to this patient's readme the psoriasis medical histories of two more than ten years is arranged, be coated with and put this product on the skin after one month, feel that obviously antipruritic effect is obvious, property of medicine gentleness is unlike exhausted those medicines in the past.Now continue to put on the skin to be coated with.
(2) model case (anaphylaxis dermatosis): certain, man, 35 years old, IT practitioner.
Diagnostic Time: on May 13rd, 2009
According to this patient's readme, go out tourism, the back of returning finds on the arm skin rubefaction is arranged, play the hillock rash and a nameless dermatitis occurred, do not draw attention, after realize a bit serious, just smear oral anti-inflammatory drug of while, but the old complaint of making a return journey all the time with various ointment.Put on the skin and be coated with this product after one month, above-mentioned condition improves, and antipruritic symptom is effectively alleviated, and the sepage position begins drying, and incrustation is now fully good subsequently.
(3) model case (skin pruritus): Tan, the woman, 65 years old, retirement was in.
Diagnostic Time: on June 7th, 2009
According to this patient's readme, retirement helped son to look after children to the strange land afterwards, whole body especially front and skin of back pruritus is very severe, think it is being not acclimatized, special band local fine earth is oral, but loses any effect, is coated with and puts this product on the skin after one month, above-mentioned condition improves, and the pruritus symptom is effectively alleviated; Now do not itched substantially.
(4) model case (skin wound ulcer): Cai, woman, 26 years old, teacher.
Diagnostic Time: on March 7th, 2010
According to this patient's readme, to wear new leather shoes and galled instep, back skin ulceration suppurates, and has used iodine tincture and so on to fail to stop skin wound and has enlarged.Put on the skin be coated with this product first quarter moon after, above-mentioned condition improves, and stops the suppuration wound surface, and very fast incrustation has been fully recovered.
(5) model case: Wang certain, man, long haul driver, 45 years old.
Diagnostic Time: on June 26th, 2010
According to this patient's readme, owing to engage in transport for a long time, commentariess on classics of always not getting better of the eczema on the buttocks used various ointment to smear, and bad during fashion, medication is just better, and drug withdrawal is the criminal just, and is very vexed, is exactly not remove root.Put on the skin and be coated with this product after one month, above-mentioned condition improves, and buttocks eczema is cured fully, and mental status takes a turn for the better thereupon, and it is also much stable to sleep.
This intellectual property of primary enforcement that all are above-mentioned is not set restriction this new product of other forms of enforcement and/or new method.Those skilled in the art will utilize this important information, and foregoing is revised, to realize similar implementation status.But all modifications or transformation belong to the right of reservation based on new product of the present invention.
The above only is preferred embodiment of the present invention, is not to be the restriction of the present invention being made other form, and any those skilled in the art may utilize the technology contents of above-mentioned announcement to be changed or be modified as the equivalent embodiment of equivalent variations.But every technical solution of the present invention content that do not break away to any simple modification, equivalent variations and remodeling that above embodiment did, still belongs to the protection domain of technical solution of the present invention according to technical spirit of the present invention.
Claims (2)
1. a medicine that is used for the treatment of the skin infection disease is characterized in that, is made up of the raw material of following weight parts:
2. the medicine that is used for the treatment of the skin infection disease as claimed in claim 1 is characterized in that, is made up of the raw material of following weight parts:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110086467 CN102166324A (en) | 2011-04-07 | 2011-04-07 | Medicament for treating skin infection diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110086467 CN102166324A (en) | 2011-04-07 | 2011-04-07 | Medicament for treating skin infection diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102166324A true CN102166324A (en) | 2011-08-31 |
Family
ID=44487767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110086467 Pending CN102166324A (en) | 2011-04-07 | 2011-04-07 | Medicament for treating skin infection diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102166324A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104606295A (en) * | 2015-02-09 | 2015-05-13 | 程贵昌 | Non-antibiotic antifungal externally used medicine |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102000291A (en) * | 2010-11-02 | 2011-04-06 | 李永胜 | Liquid, powder, capsules and paste for preventing and treating gynecology |
-
2011
- 2011-04-07 CN CN 201110086467 patent/CN102166324A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102000291A (en) * | 2010-11-02 | 2011-04-06 | 李永胜 | Liquid, powder, capsules and paste for preventing and treating gynecology |
Non-Patent Citations (2)
| Title |
|---|
| 《中华中医药学刊》 20100331 张景红,冯汗青,李红玉 雄黄微生物提取液诱导K562 /ADM细胞凋亡的作用机制研究 533-537 1-2 第28卷, 第3期 2 * |
| 《中国油料作物学报》 19950228 陈连官; 鹤虱籽精油的提取与利用 50-53 1-2 第17卷, 第2期 2 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104606295A (en) * | 2015-02-09 | 2015-05-13 | 程贵昌 | Non-antibiotic antifungal externally used medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Panahi et al. | A randomized comparative trial on the therapeutic efficacy of topical aloe vera and Calendula officinalis on diaper dermatitis in children | |
| Purbafrani et al. | The benefits of honey in Holy Quran | |
| Pulipati et al. | An overview on urinary tract infections and effective natural remedies | |
| CN102943006A (en) | Essential oil soap with bacterial killing and bacterial inhibiting functions | |
| US20070098671A1 (en) | Composition and method of treatment for irritated skin | |
| Akanda et al. | Honey for nutrition and health benefits: an overview | |
| CN115844993A (en) | A Chinese medicinal disinfectant for oral cavity and skin, and its preparation method | |
| CN102166324A (en) | Medicament for treating skin infection diseases | |
| De Souza et al. | SilverSol® a Nano-Silver Preparation: A Multidimensional Approach to Advanced Wound Healing | |
| CN102178748B (en) | External medicament for treating ulcer | |
| CN101810720A (en) | Skin disease external powder for comprehensively killing and inhibiting bacteria and diminishing inflammation and using method thereof to beriberi skin disease | |
| WO2021258654A1 (en) | Silver ion antibacterial hand sanitizer, preparation method therefor, and application thereof | |
| CN106377602A (en) | Dendrobium officinale composite disinfection powder, and preparation method and application method thereof | |
| CN105267273A (en) | Natural skin-protecting wound disinfectant and preparation method thereof | |
| CN101376870B (en) | Chinese herbal medicine wine capable of activating blood circulation, removing stasis, expelling toxin and relieving itching | |
| CN108079050A (en) | Herbal skin bacteria inhibiting composition and preparation method and application | |
| CN104000959A (en) | Traditional Chinese medicine composition for external use and application thereof | |
| CN102178729B (en) | Chinese medicinal bath fluid for preventing and treating neonate impetigos and preparation method thereof | |
| CN101129565B (en) | Medicament for treating beriberi, sweaty feet and foot odor | |
| Alam et al. | Nature’s Remedies: Unlocking the Therapeutic Potential of Honey and Propolis | |
| Ghosh et al. | Antimicrobial applications of clays and their derivatives in protection of human health | |
| CN101204399B (en) | External medicine for tinea pedis | |
| KR20190045050A (en) | Food composition for treating cold and flu | |
| de Souza et al. | SilverSol® a Nano-Silver Preparation: A | |
| CN109248099A (en) | A kind of stable high oxidation electrolyzed-oxidizing water sterilization creme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20110831 |